felbamate

Modify Date: 2024-01-02 08:14:45

felbamate Structure
felbamate structure
Common Name felbamate
CAS Number 25451-15-4 Molecular Weight 238.240
Density 1.3±0.1 g/cm3 Boiling Point 511.9±50.0 °C at 760 mmHg
Molecular Formula C11H14N2O4 Melting Point 148-1500C
MSDS Chinese USA Flash Point 288.4±26.4 °C
Symbol GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
Signal Word Danger

 Use of felbamate


Felbamate (FBM) is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate (NMDA) .Target: NMDA ReceptorFelbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy.Felbamate has been proposed to a unique dual mechanism of action as a positive modulator of GABAA receptors and as a blocker of NMDA receptors, particularly isoforms containing the NR2B subunit. Although it is clear that felbamate does cause pharmacological inhibition of NMDA receptor of relevance of NMDA receptor blockade as a strategy for the treatment of human epilepsy has been questioned. Therefore, the importance of the effects of felbamate on NMDA receptors to its therapeutic action in epilepsy is uncertain.

 Names

Name felbamate
Synonym More Synonyms

 felbamate Biological Activity

Description Felbamate (FBM) is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate (NMDA) .Target: NMDA ReceptorFelbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy.Felbamate has been proposed to a unique dual mechanism of action as a positive modulator of GABAA receptors and as a blocker of NMDA receptors, particularly isoforms containing the NR2B subunit. Although it is clear that felbamate does cause pharmacological inhibition of NMDA receptor of relevance of NMDA receptor blockade as a strategy for the treatment of human epilepsy has been questioned. Therefore, the importance of the effects of felbamate on NMDA receptors to its therapeutic action in epilepsy is uncertain.
Related Catalog
References

[1]. Kuo CC, et al. Use-dependent inhibition of the N-methyl-D-aspartate currents by felbamate: a gating modifier with selective binding to the desensitized channels. Mol Pharmacol. 2004 Feb;65(2):370-80.

[2]. Harty TP, et al. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit. Epilepsy Res. 2000 Mar;39(1):47-55.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 511.9±50.0 °C at 760 mmHg
Melting Point 148-1500C
Molecular Formula C11H14N2O4
Molecular Weight 238.240
Flash Point 288.4±26.4 °C
Exact Mass 238.095352
PSA 104.64000
LogP 1.20
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.559
Storage condition Store at RT
Water Solubility alcohol: soluble

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TZ1070000
CHEMICAL NAME :
1,3-Propanediol, 2-phenyl-, dicarbamate
CAS REGISTRY NUMBER :
25451-15-4
BEILSTEIN REFERENCE NO. :
3345236
LAST UPDATED :
199806
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C11-H14-N2-O4
MOLECULAR WEIGHT :
238.27
WISWESSER LINE NOTATION :
ZVO1YR&1OVZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
140 mg/kg
TOXIC EFFECTS :
Behavioral - sleep
REFERENCE :
PECAE5 Pediatric Emergency Care. (Williams & Wilkins, 428 E. Preston St., Baltimore, MD 21202) V.1- 1985- Volume(issue)/page/year: 11,369,1995
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
1296 mg/kg/18D-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - effect, not otherwise specified Gastrointestinal - other changes Skin and Appendages - dermatitis, other (after systemic exposure)
REFERENCE :
PHPYDQ Pharmacotherapy (Carlisle, MA). (Pharmacotherapy Pub., Inc., 112 School St., Carlisle, MA 01741) V.1- 1981- Volume(issue)/page/year: 15,260,1995
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,931,1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,931,1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 12,462,1969

 Safety Information

Symbol GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
Signal Word Danger
Hazard Statements H225-H301 + H311 + H331-H370
Precautionary Statements P210-P260-P280-P301 + P310-P311
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR UN1230 - class 3 - PG 2 - Methanol
WGK Germany 2
RTECS TZ1070000
HS Code 2924299090

 Synthetic Route

~%

felbamate Structure

felbamate

CAS#:25451-15-4

Literature: WO2012/32508 A1, ; Page/Page column 6 ;

~80%

felbamate Structure

felbamate

CAS#:25451-15-4

Literature: Macdonald, Timothy L. Patent: US2002/156070 A1, 2002 ;

~%

felbamate Structure

felbamate

CAS#:25451-15-4

Literature: Chemical Research in Toxicology, , vol. 10, # 4 p. 457 - 462

~%

felbamate Structure

felbamate

CAS#:25451-15-4

Literature: US2009/111871 A1, ; Page/Page column 3 ;

~%

felbamate Structure

felbamate

CAS#:25451-15-4

Literature: Chemical Research in Toxicology, , vol. 10, # 4 p. 457 - 462

~%

felbamate Structure

felbamate

CAS#:25451-15-4

Literature: WO2012/32508 A1, ;

~%

felbamate Structure

felbamate

CAS#:25451-15-4

Literature: US2884444 , ;

 Customs

HS Code 2924299090
Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 Articles46

More Articles
Pediatric super-refractory status epilepticus treated with allopregnanolone.

Ann. Neurol. 76(6) , 911-5, (2014)

Super-refractory status epilepticus is a life-threatening condition. Resistance to benzodiazepine and barbiturate treatment for this disorder is thought to be due to internalization of synaptic γ-amin...

Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures.

Pharmacol. Rep. 59(4) , 462-6, (2007)

The efficacy of lamotrigine and felbamate against maximal electroshock (MES)-induced seizures was assessed under conditions mimicking the pharmacoresistance associated with an increased excitatory neu...

Behavioral and cognitive effects of anti-epileptic drugs.

Discov. Med. 9(45) , 138-44, (2010)

Anti-epileptic drugs (AEDs) have a variety of mechanisms of action which are reflected through different anticonvulsant activities and behavioral effects. Two categories of AEDs are considered based o...

 Synonyms

Felbatol
3-propanediol dicarbamate
EINECS 247-001-4
Felbamatum
Felbamato
1,3-Propanediol,2-phenyl-,dicarbamate
1,3-bis-carbamoyloxy-2-phenyl-propane
1,3-Bis-carbamoyloxy-2-phenyl-propan
MFCD00865296
2-Phenyl-1,3-propanediyl dicarbamate
felbamate
Felbamyl
(3-carbamoyloxy-2-phenylpropyl) carbamate
Carbamic acid,2-phenyltrimethylene ester
1,3-Propanediol, 2-phenyl-, dicarbamate
Taloxa
2-Phenylpropane-1,3-diyl dicarbamate
2-phenyl-1,3-propanediol dicarbamate
Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: Felbamate
  • Price: $400.0/100mg $700.0/250mg $1300.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao


Get all suppliers and price by the below link:

felbamate suppliers


Price: $66/10mM*1mLinDMSO

Reference only. check more felbamate price